Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
JPMorgan Upgrades Bruker (BRKR) to Overweight
February 13, 2024 4:24 PM ESTJPMorgan analyst Tycho W. Peterson upgraded Bruker (NASDAQ: BRKR) from Neutral to Overweight with a price target of $90.00 (from $60.00).
The analyst comments "This morning, Bruker (BRKR) reported a sizeable 4Q beat while initiating better-than-expected 2024 guidance and, most notably, pulled forward its 2026 revenue and non-GAAP EPS LRP targets to 2025 (implying >30% non-GAAP EPS growth in 2025). Strength across regions and end-markets is driven by secular trends in proteomics and other omics research in what the company describes as the... More
Bruker (BRKR) Tops Q4 EPS by 2c
February 13, 2024 7:03 AM ESTBruker (NASDAQ: BRKR) reported Q4 EPS of $0.70, $0.02 better than the analyst estimate of $0.68. Revenue for the quarter came in at $854.4 million versus the consensus estimate of $803.81 million.
For earnings history and earnings-related data on Bruker (BRKR) click here.
... More